Cargando…

Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China

BACKGROUND: Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC in South China in the past half‐century. METHODS: This study retrospectively included 59 patients with ASCC a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yan, Xie, Wei‐Hao, Li, Rong‐Zhen, Chang, Hui, Zeng, Zhi‐Fan, Gao, Yuan‐Hong, Wang, Qiao‐Xuan, Xiao, Wei‐Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704146/ https://www.ncbi.nlm.nih.gov/pubmed/34816622 http://dx.doi.org/10.1002/cam4.4433

Ejemplares similares

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
por: Zhou, Ting, et al.
Publicado: (2019)

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma
por: Yang, Ningning, et al.
Publicado: (2021)

Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience
por: Hagemans, J. A. W., et al.
Publicado: (2018)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019)

Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
por: Jani, Krupa S., et al.
Publicado: (2021)

A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer
por: Faber, Mette T., et al.
Publicado: (2022)

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis
por: Xiao, WeiWei, et al.
Publicado: (2022)

Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database
por: Bian, Shelly X., et al.
Publicado: (2020)

A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
por: Clifford, Gary M., et al.
Publicado: (2020)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
por: Smaglo, Brandon G., et al.
Publicado: (2015)

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

Limited Value of Staging Squamous Cell Carcinoma of the Anal Margin and Canal Using the Sentinel Lymph Node Procedure: A Prospective Study with Long-Term Follow-Up
por: de Jong, Johannes S., et al.
Publicado: (2010)

Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer
por: Yan, Li-rong, et al.
Publicado: (2021)

Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls
por: Dai, Yingqi, et al.
Publicado: (2019)

Environmental scan of anal cancer screening practices: worldwide survey results
por: Patel, Jigisha, et al.
Publicado: (2014)

Squamous cell carcinoma of upper alveolus: An experience of a tertiary care center of Northeast India
por: Baishya, Nizara, et al.
Publicado: (2019)

Nomograms for predicting long‐term overall survival and cancer‐specific survival in lip squamous cell carcinoma: A population‐based study
por: Hu, Chuan-Yu, et al.
Publicado: (2019)

The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles
por: Zhang, Yongping, et al.
Publicado: (2020)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9
por: Lv, Yuan, et al.
Publicado: (2019)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis
por: Qin, Yuan, et al.
Publicado: (2021)

A rigorous exploration of anal HPV genotypes using a next‐generation sequencing (NGS) approach in HIV‐infected men who have sex with men at risk for developing anal cancer
por: Piyathilake, Chandrika J., et al.
Publicado: (2019)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Anal Intraepithelial Neoplasia: Precursor of Anal Squamous Cell Carcinoma
por: Sakamoto, Taku, et al.
Publicado: (2022)

MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer
por: Fan, Xingchen, et al.
Publicado: (2021)

Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China
por: Shan, Xia, et al.
Publicado: (2018)

Milk and dairy products consumption and the risk of oral or oropharyngeal cancer: a meta-analysis
por: Yuan, Jian, et al.
Publicado: (2019)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway
por: Huang, Yun, et al.
Publicado: (2020)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015)

MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR
por: Jia, Tingting, et al.
Publicado: (2020)

Detection of Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma on Colonoscopy
por: Voss, Jordan K., et al.
Publicado: (2022)

VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)
por: Feliu, Jaime, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m7k937nt1ckci0patn44jllsqd